NOVAVAX INC Quarterly Operating Margin in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Novavax Inc quarterly/annual Operating Margin history and growth rate from Q4 2011 to Q3 2024.
  • Novavax Inc Operating Margin for the quarter ending September 30, 2024 was -34.1 %, a 43% increase year-over-year.
  • Novavax Inc annual Operating Margin for 2023 was -57.6 %, a 77% decline from 2022.
  • Novavax Inc annual Operating Margin for 2022 was -32.5 %, a 77.9% increase from 2021.
  • Novavax Inc annual Operating Margin for 2021 was -147 %, a 67.9% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -34.1 +25.7 +43% Jul 1, 2024 Sep 30, 2024
Q2 2024 -29.7 +9.67 +24.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -40 +45.9 +53.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -57.6 -25.1 -77% Oct 1, 2023 Dec 31, 2023
Q3 2023 -59.7 +6.67 +10% Jul 1, 2023 Sep 30, 2023
Q2 2023 -39.3 +69.6 +63.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -85.9 +4.56 +5.04% Jan 1, 2023 Mar 31, 2023
Q4 2022 -32.5 +115 +77.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -66.4 +20.4 +23.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -109 -30.1 -38.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -90.4 -24.9 -38% Jan 1, 2022 Mar 31, 2022
Q4 2021 -147 -59.5 -67.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -86.8 +41.5 +32.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -78.8 +87.7 +52.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -65.5 +506 +88.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -87.6 +559 +86.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -128 +738 +85.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -166 +613 +78.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -572 +24.4 +4.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -646 -139 -27.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -866 -412 -90.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -780 -333 -74.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -596 -100 -20.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -507 +43.6 +7.91% Oct 1, 2018 Dec 31, 2018
Q3 2018 -454 +226 +33.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -446 +502 +53% Apr 1, 2018 Jun 30, 2018
Q1 2018 -496 +899 +64.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -551 +1.2K +68.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -680 +1.18K +63.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -949 +433 +31.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -1.4K -715 -105% Jan 1, 2017 Mar 31, 2017
Q4 2016 -1.75K -1.32K -304% Oct 1, 2016 Dec 31, 2016
Q3 2016 -1.86K -1.56K -528% Jul 1, 2016 Sep 30, 2016
Q2 2016 -1.38K -1.13K -455% Apr 1, 2016 Jun 30, 2016
Q1 2016 -681 -397 -140% Jan 1, 2016 Mar 31, 2016
Q4 2015 -434 -161 -58.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -296 -93.5 -46.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -249 -37.9 -17.9% Apr 1, 2015 Jun 30, 2015
Q1 2015 -283 -51.6 -22.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -273 -22.3 -8.88% Oct 1, 2014 Dec 31, 2014
Q3 2014 -203 +82.1 +28.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 -211 +10.8 +4.85% Apr 1, 2014 Jun 30, 2014
Q1 2014 -231 -80.1 -52.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -251 -116 -86.6% Oct 1, 2013 Dec 31, 2013
Q3 2013 -285 -180 -172% Jul 1, 2013 Sep 30, 2013
Q2 2013 -222 -126 -133% Apr 1, 2013 Jun 30, 2013
Q1 2013 -151 -34.6 -29.6% Jan 1, 2013 Mar 31, 2013
Q4 2012 -134 +12.6 +8.54% Oct 1, 2012 Dec 31, 2012
Q3 2012 -105 Jul 1, 2012 Sep 30, 2012
Q2 2012 -95.4 Apr 1, 2012 Jun 30, 2012
Q1 2012 -117 Jan 1, 2012 Mar 31, 2012
Q4 2011 -147 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.